Larvol Delta - Ankyra-Therapeutics-Announces-Promising-Preclinical-Data-on-ANK101-a-Novel-Anchored-Immune-Medicine-in-Combination-with-Cytotoxic-Chemotherapy-in-Head-and-Neck-Cancer-Model

ANK-101 - Ankyra Therap

https://www.businesswire.com/news/home/20231103290012/en/Ankyra-Therapeutics-Announces-Promising-Preclinical-Data-on-ANK-101-a-Novel-Anchored-Immune-Medicine-in-Combination-with-Cytotoxic-Chemotherapy-in-Head-and-Neck-Cancer-Model

Nov 3, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next